ENOV

25.4702.90%
DM

Damien McDonald

CEO & Director

Mr. Damien McDonald serves as Chief Executive Officer of Enovis Corporation since May 12, 2025 and serves as Director since May 2025. Mr. McDonald was the Chief Executive Officer and an Executive Director of LivaNova PLC since January 1, 2017 until April 15, 2023. Mr. McDonald served as Chief Operating Officer of LivaNova from October 3, 2016 through December 31, 2016. Prior to joining us, Mr. McDonald held several senior roles in the global life sciences sector. Most recently, Mr. McDonald was Group Executive and Corporate Vice President at Danaher Corporation (?Danaher?). From 2013 until 2016, he served as Group President, Professional Consumables at Danaher. During his tenure at Danaher, he was responsible for, among other things, 13 operating plants in Europe and the Americas and over 3,200 employees globally. From 2011 to 2013, Mr. McDonald served as Group President of Kerr Corporation, a subsidiary of Danaher, where he was responsible for a dental consumables business with operations in the United States, Mexico, Switzerland, Italy and the Czech Republic. In 2010, Mr. McDonald undertook special projects for Danaher. From 2007 to 2010, Mr. McDonald was President, Zimmer Spine at Zimmer Holdings, where he was responsible for divisions in the United States and France. From 1999 to 2007, Mr. McDonald occupied various roles with Merck & Co and Johnson & Johnson. He was an Independent Non-Executive Director of AVITA Therapeutics, Inc. (formerly known as Avita Medical Limited) since January 13, 2016 until November 9, 2020. Mr. McDonald holds bachelor?s degrees in pharmacy and economics from the University of Queensland in Australia, a master?s degree in international economics from the University of Wales and an MBA from the Institute for Management Development in Lausanne.

Positions